171 related articles for article (PubMed ID: 29797786)
1. Generation of High Expressing Chinese Hamster Ovary Cell Pools Using the Leap-In Transposon System.
Balasubramanian S; Peery RB; Minshull J; Lee M; White R; Kelly RM; Barnard GC
Biotechnol J; 2018 Oct; 13(10):e1700748. PubMed ID: 29797786
[TBL] [Abstract][Full Text] [Related]
2. Bioreactor scale up and protein product quality characterization of piggyBac transposon derived CHO pools.
Rajendra Y; Balasubramanian S; Peery RB; Swartling JR; McCracken NA; Norris DL; Frye CC; Barnard GC
Biotechnol Prog; 2017 Mar; 33(2):534-540. PubMed ID: 28188692
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of piggyBac-mediated CHO pools to enable material generation to support GLP toxicology studies.
Rajendra Y; Balasubramanian S; McCracken NA; Norris DL; Lian Z; Schmitt MG; Frye CC; Barnard GC
Biotechnol Prog; 2017 Nov; 33(6):1436-1448. PubMed ID: 28547769
[TBL] [Abstract][Full Text] [Related]
4. Utilizing targeted integration CHO pools to potentially accelerate the GMP manufacturing of monoclonal and bispecific antibodies.
Barnard GC; Zhou M; Shen A; Yuk IH; Laird MW
Biotechnol Prog; 2024; 40(1):e3399. PubMed ID: 37874920
[TBL] [Abstract][Full Text] [Related]
5. Generation of stable Chinese hamster ovary pools yielding antibody titers of up to 7.6 g/L using the piggyBac transposon system.
Rajendra Y; Peery RB; Barnard GC
Biotechnol Prog; 2016 Sep; 32(5):1301-1307. PubMed ID: 27254818
[TBL] [Abstract][Full Text] [Related]
6. Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells.
Chng J; Wang T; Nian R; Lau A; Hoi KM; Ho SC; Gagnon P; Bi X; Yang Y
MAbs; 2015; 7(2):403-12. PubMed ID: 25621616
[TBL] [Abstract][Full Text] [Related]
7. Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability.
Ho SC; Koh EY; van Beers M; Mueller M; Wan C; Teo G; Song Z; Tong YW; Bardor M; Yang Y
J Biotechnol; 2013 Jun; 165(3-4):157-66. PubMed ID: 23583871
[TBL] [Abstract][Full Text] [Related]
8. Rapid recombinant protein production from piggyBac transposon-mediated stable CHO cell pools.
Balasubramanian S; Matasci M; Kadlecova Z; Baldi L; Hacker DL; Wurm FM
J Biotechnol; 2015 Apr; 200():61-9. PubMed ID: 25758242
[TBL] [Abstract][Full Text] [Related]
9. Recombinant CHO Cell Pool Generation Using PiggyBac Transposon System.
Balasubramanian S
Methods Mol Biol; 2024; 2810():137-146. PubMed ID: 38926277
[TBL] [Abstract][Full Text] [Related]
10. Recombinant CHO Cell Pool Generation Using piggyBac Transposon System.
Balasubramanian S
Methods Mol Biol; 2018; 1850():69-78. PubMed ID: 30242681
[TBL] [Abstract][Full Text] [Related]
11. Accelerating and de-risking CMC development with transposon-derived manufacturing cell lines.
Rajendran S; Balasubramanian S; Webster L; Lee M; Vavilala D; Kulikov N; Choi J; Tang C; Hunter M; Wang R; Kaur H; Karunakaran S; Sitaraman V; Minshull J; Boldog F
Biotechnol Bioeng; 2021 Jun; 118(6):2301-2311. PubMed ID: 33704772
[TBL] [Abstract][Full Text] [Related]
12. Rapid cGMP manufacturing of COVID-19 monoclonal antibody using stable CHO cell pools.
Agostinetto R; Rossi M; Dawson J; Lim A; Simoneau MH; Boucher C; Valldorf B; Ross-Gillespie A; Jardine JG; Sok D; Burton DR; Hassell T; Broly H; Palinsky W; Dupraz P; Feinberg M; Dey AK
Biotechnol Bioeng; 2022 Feb; 119(2):663-666. PubMed ID: 34796474
[TBL] [Abstract][Full Text] [Related]
13. Repressing expression of difficult-to-express recombinant proteins during the selection process increases productivity of CHO stable pools.
Maltais JS; Lord-Dufour S; Morasse A; Stuible M; Loignon M; Durocher Y
Biotechnol Bioeng; 2023 Oct; 120(10):2840-2852. PubMed ID: 37232536
[TBL] [Abstract][Full Text] [Related]
14. Towards maximum acceleration of monoclonal antibody development: Leveraging transposase-mediated cell line generation to enable GMP manufacturing within 3 months using a stable pool.
Schmieder V; Fieder J; Drerup R; Gutierrez EA; Guelch C; Stolzenberger J; Stumbaum M; Mueller VS; Higel F; Bergbauer M; Bornhoefft K; Wittner M; Gronemeyer P; Braig C; Huber M; Reisenauer-Schaupp A; Mueller MM; Schuette M; Puengel S; Lindner B; Schmidt M; Schulz P; Fischer S
J Biotechnol; 2022 Apr; 349():53-64. PubMed ID: 35341894
[TBL] [Abstract][Full Text] [Related]
15. Diversity in host clone performance within a Chinese hamster ovary cell line.
O'Callaghan PM; Berthelot ME; Young RJ; Graham JW; Racher AJ; Aldana D
Biotechnol Prog; 2015; 31(5):1187-200. PubMed ID: 25918883
[TBL] [Abstract][Full Text] [Related]
16. Genomic features of recombinant CHO clones arising from transposon-based and randomized integration.
Huhn SC; Chang M; Jiang B; Tang X; Betenbaugh M; Du Z
J Biotechnol; 2023 Aug; 373():73-81. PubMed ID: 37271453
[TBL] [Abstract][Full Text] [Related]
17. A study of monoclonal antibody-producing CHO cell lines: what makes a stable high producer?
Chusainow J; Yang YS; Yeo JH; Toh PC; Asvadi P; Wong NS; Yap MG
Biotechnol Bioeng; 2009 Mar; 102(4):1182-96. PubMed ID: 18979540
[TBL] [Abstract][Full Text] [Related]
18. Transient and stable CHO expression, purification and characterization of novel hetero-dimeric bispecific IgG antibodies.
Rajendra Y; Peery RB; Hougland MD; Barnard GC; Wu X; Fitchett JR; Bacica M; Demarest SJ
Biotechnol Prog; 2017 Mar; 33(2):469-477. PubMed ID: 27977915
[TBL] [Abstract][Full Text] [Related]
19. Comparison of three transposons for the generation of highly productive recombinant CHO cell pools and cell lines.
Balasubramanian S; Rajendra Y; Baldi L; Hacker DL; Wurm FM
Biotechnol Bioeng; 2016 Jun; 113(6):1234-43. PubMed ID: 26616356
[TBL] [Abstract][Full Text] [Related]
20. The PiggyBac transposon enhances the frequency of CHO stable cell line generation and yields recombinant lines with superior productivity and stability.
Matasci M; Baldi L; Hacker DL; Wurm FM
Biotechnol Bioeng; 2011 Sep; 108(9):2141-50. PubMed ID: 21495018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
